Cargando…
RXRα ligand Z-10 induces PML-RARα cleavage and APL cell apoptosis through disrupting PML-RARα/RXRα complex in a cAMP-independent manner
The major oncogenic driver of acute promyelocytic leukemia (APL) is the fusion protein PML-RARα originated from the chromosomal translocation t(15;17). All-trans retinoic acid (ATRA) and arsenic trioxide cure most patients by directly targeting PML-RARα. However, major issues including the resistanc...
Autores principales: | Xu, Lin, Zeng, Zhiping, Zhang, Weidong, Ren, Gaoang, Ling, Xiaobin, Huang, Fengyu, Xie, Peizhen, Su, Ying, Zhang, Xiao-kun, Zhou, Hu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355346/ https://www.ncbi.nlm.nih.gov/pubmed/28129653 http://dx.doi.org/10.18632/oncotarget.14812 |
Ejemplares similares
-
Targeting TRIB3 and PML-RARα interaction against APL
por: Li, Ke, et al.
Publicado: (2017) -
Regulation of NF-κB by PML and PML-RARα
por: Ahmed, Abrar, et al.
Publicado: (2017) -
PML-RARα interaction with TRIB3 impedes PPARγ/RXR function and triggers dyslipidemia in acute promyelocytic leukemia
por: Li, Ke, et al.
Publicado: (2020) -
Regulation of RXR-RAR Heterodimers by RXR- and RAR-Specific Ligands and Their Combinations
por: le Maire, Albane, et al.
Publicado: (2019) -
Targeting the Acute Promyelocytic Leukemia-Associated Fusion Proteins PML/RARα and PLZF/RARα with Interfering Peptides
por: Beez, Sabine, et al.
Publicado: (2012)